Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Liabilities (2021 - 2025)

PAVmed (PAVM) has 5 years of Total Liabilities data on record, last reported at $12.3 million in Q3 2025.

  • For Q3 2025, Total Liabilities changed N/A year-over-year to $12.3 million; the TTM value through Sep 2025 reached $12.3 million, changed N/A, while the annual FY2024 figure was $37.7 million, 34.03% down from the prior year.
  • Total Liabilities reached $12.3 million in Q3 2025 per PAVM's latest filing, down from $12.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $58.1 million in Q2 2024 and bottomed at $3.3 million in Q1 2021.
  • Average Total Liabilities over 5 years is $31.7 million, with a median of $37.7 million recorded in 2024.
  • Peak YoY movement for Total Liabilities: surged 670.02% in 2022, then crashed 79.44% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $7.6 million in 2021, then skyrocketed by 469.54% to $43.0 million in 2022, then skyrocketed by 32.73% to $57.1 million in 2023, then plummeted by 34.03% to $37.7 million in 2024, then tumbled by 67.42% to $12.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $12.3 million in Q3 2025, $12.5 million in Q2 2025, and $11.9 million in Q1 2025.